Navigation Links
Time is ripe to take stock of depression

It’s not difficult to take a guess on what could be top of the heap among Britain’s maladies. Depression and chronic anxiety, now out in the open as a common affliction// , needs urgent remedy, because this is one mental health issue that is threatening to become a social problem.

It is estimated that nearly one million people avail an incapacity benefit due to this debilitating ailment that renders them unemployed. Sadly, most of the sufferers do not avail proper treatment. Now, the National Institute for Health and Clinical Excellence (Nice) has laid down procedures that direct specialists to offer the choice of psychological therapy to the patients. Often, due to all mental health treatments being drug-driven, patients tend to get wary of seeking help.

The success rate of psychological therapies is being established. Infact with as little as 16 sessions, nearly 50% of the patients are able to find a cure. Cognitive behavioral therapy, on par with the efficacy of drugs, proves better in the long run and helps preventing a relapse.

The unfortunate bit about psychological therapy is there are too few therapists available to render timely help. Unbelievably, people are waiting for over months to meet with therapists. The need of the hour is to enable psychological thereapy services in every area, which can be availed by the patients.


'"/>




Page: 1

Related medicine news :

1. Risk of deep vein thrombosis less in people who were flight stockings when flying
2. Health and Human Services stockpiles 20 million bird flu Vaccines
3. Rich countries stock piling anti flu drugs with no stocks available for poor countries
4. Bird flu: the threat causes lowering in poultry stocks
5. Burma Restocks Poultry Farms Again
6. Depleting stock of antiretroviral drugs in Uganda raises concern
7. Companies ensure enough stock of bird flu drug
8. India Develops Test for Diagnosis of Deadly Livestock Disease
9. Netherlands to lift livestock restrictions over avian influenza
10. Switzerland to stock bird flu vaccine
11. New treatment for depression
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: